Clinical Trial Detail

NCT ID NCT01689974
Title Phase II Randomized Trial of Ipilimumab Versus Ipilimumab and Radiotherapy in Metastatic Melanoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors New York University School of Medicine
Indications

melanoma

Therapies

Ipilimumab

Age Groups: adult

No variant requirements are available.